177 related articles for article (PubMed ID: 38396558)
1. Metabolic and Endocrine Insights in Donkeys.
Mendoza FJ; Toribio RE; Perez-Ecija A
Animals (Basel); 2024 Feb; 14(4):. PubMed ID: 38396558
[TBL] [Abstract][Full Text] [Related]
2. BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction.
Menzies-Gow NJ; Banse HE; Duff A; Hart N; Ireland JL; Knowles EJ; McFarlane D; Rendle D
Equine Vet J; 2024 Mar; 56(2):220-242. PubMed ID: 37795557
[TBL] [Abstract][Full Text] [Related]
3. Pituitary Pars Intermedia Dysfunction and Metabolic Syndrome in Donkeys.
Gehlen H; Schwarz B; Bartmann C; Gernhardt J; Stöckle SD
Animals (Basel); 2020 Dec; 10(12):. PubMed ID: 33302557
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dynamic testing for pituitary pars intermedia dysfunction diagnosis in donkeys.
Mejia-Pereira S; Perez-Ecija A; Buchanan BR; Toribio RE; Mendoza FJ
Equine Vet J; 2019 Jul; 51(4):481-488. PubMed ID: 30362589
[TBL] [Abstract][Full Text] [Related]
6. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.
Kirkwood NC; Hughes KJ; Stewart AJ
Vet Sci; 2022 Oct; 9(10):. PubMed ID: 36288169
[TBL] [Abstract][Full Text] [Related]
7. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management.
Spelta CW
Vet Med (Auckl); 2015; 6():293-300. PubMed ID: 30101114
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the combined glucose-insulin and intravenous glucose tolerance tests for insulin dysregulation diagnosis in donkeys.
Mendoza FJ; Mejia-Moreira S; Buchanan BR; Toribio RE; Perez-Ecija A
Equine Vet J; 2022 May; 54(3):531-540. PubMed ID: 34109681
[TBL] [Abstract][Full Text] [Related]
9. Association between insulin dysregulation and adrenocorticotropic hormone in aged horses and ponies with no clinical signs of pituitary pars intermedia dysfunction.
Li FI; Spence RJ; de Laat MA; Harris PA; Sonntag J; Menzies-Gow NJ; Durham AE; Bailey SR; Sillence MN
Equine Vet J; 2023 Nov; 55(6):1003-1011. PubMed ID: 36641787
[TBL] [Abstract][Full Text] [Related]
10. Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses.
Miller AB; Loynachan AT; Bush HM; Hart KA; Barker VD; Campana-Emard AG; Grubbs ST; Adams AA
Domest Anim Endocrinol; 2021 Jan; 74():106531. PubMed ID: 32942194
[TBL] [Abstract][Full Text] [Related]
11. The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.
Meier AD; de Laat MA; Reiche DB; Pollitt CC; Walsh DM; McGree JM; Sillence MN
Domest Anim Endocrinol; 2018 Apr; 63():1-9. PubMed ID: 29172109
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and Endocrine Disorders in Donkeys.
Mendoza FJ; Toribio RE; Perez-Ecija A
Vet Clin North Am Equine Pract; 2019 Dec; 35(3):399-417. PubMed ID: 31587976
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of pergolide mesylate after oral administration in horses with pituitary pars intermedia dysfunction.
Rendle DI; Doran G; Ireland J; Edwards S
Domest Anim Endocrinol; 2019 Jul; 68():135-141. PubMed ID: 31082785
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
15. Management of pituitary pars intermedia dysfunction in practice: A clinical audit.
Steel NL; Ireland JL; McGowan CM
Vet J; 2022 Nov; 289():105899. PubMed ID: 36162625
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
Horn R; Bertin FR
J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
[TBL] [Abstract][Full Text] [Related]
17. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
[TBL] [Abstract][Full Text] [Related]
18. Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID).
Kirkwood NC; Hughes KJ; Stewart AJ
Vet Sci; 2022 Oct; 9(10):. PubMed ID: 36288186
[TBL] [Abstract][Full Text] [Related]
19. Seasonal variation of endogenous adrenocorticotropic hormone concentrations in healthy non-geriatric donkeys in Northern California.
Humphreys S; Kass PH; Magdesian KG; Goodrich E; Berryhill E
Front Vet Sci; 2022; 9():981920. PubMed ID: 36032308
[TBL] [Abstract][Full Text] [Related]
20. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis.
Kellon EM; Gustafson KM
Open Vet J; 2022; 12(4):511-518. PubMed ID: 36118716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
